By Counterforce Health Team in Vigabatrin (generic; Sabril originator Lundbeck) —

How to Get Vigabatrin (Sabril) Covered by Blue Cross Blue Shield in New York: Complete REMS & Appeal Guide

Answer Box: Getting Vigabatrin Covered by BCBS New York

Quick path to approval: Complete REMS enrollment for prescriber, patient, and pharmacy first, then submit BCBS prior authorization with documented seizure history and vision monitoring plan. If denied, use New York's external appeal process through DFS within 4 months.

First step today: Verify your specific BCBS plan (Empire, Excellus, Highmark) and download their current vigabatrin PA form. Ensure your neurologist is certified in the Vigabatrin REMS Program.

Timeline: PA decisions typically within 15 days; internal appeals within 30 days; external appeals through NY DFS within 30 days of complete filing.

Table of Contents

  1. BCBS Plan Types and Policies
  2. FDA Requirements and REMS Enrollment
  3. Step Therapy and Medical Exceptions
  4. Quantity Limits and Renewal Rules
  5. Required Diagnostics and Documentation
  6. Specialty Pharmacy Requirements
  7. Evidence for Medical Necessity
  8. Appeals Process in New York
  9. Common Denial Reasons & Solutions
  10. Cost Assistance Options

BCBS Plan Types and Policies

Blue Cross Blue Shield in New York operates through several independent entities, each with distinct formularies and prior authorization requirements:

  • Empire BlueCross BlueShield (Anthem affiliate)
  • Excellus BlueCross BlueShield
  • HealthNow New York (Highmark affiliate)
  • Capital District Physicians' Health Plan

All require prior authorization for vigabatrin (both generic and brand Sabril), but specific forms and submission processes vary. Check your insurance card to identify your exact BCBS entity, then download their current PA form from their provider portal.

Note: Federal Employee Program (FEP) Blue Cross follows national policies but may have different timelines and appeal processes.

FDA Requirements and REMS Enrollment

Vigabatrin is only available through the FDA-mandated Vigabatrin REMS Program due to risk of permanent vision loss. No prescription can be filled without complete REMS compliance.

Prescriber Requirements

  • Complete one-time certification at vigabatrinrems.com
  • Review prescribing information and agree to counsel patients
  • Arrange baseline and periodic vision assessments
  • Document counseling and monitoring in patient records

Patient Requirements

  • Sign Patient/Parent/Legal-Guardian-Physician Agreement Form
  • Acknowledge understanding of vision loss risk
  • Commit to regular ophthalmologic monitoring (typically every 3 months)
  • Use only REMS-certified pharmacies

Pharmacy Requirements

  • Complete pharmacy certification through REMS program
  • Verify prescriber and patient enrollment before each dispense
  • Maintain staff training on REMS compliance

Critical: BCBS will deny any vigabatrin request without proof of complete REMS enrollment for all three parties.

Step Therapy and Medical Exceptions

Infantile Spasms (Ages 1 month - 2 years)

BCBS typically covers vigabatrin as first-line for infantile spasms without step therapy requirements, but requires:

  • Neurologist or pediatric neurologist prescription
  • Clear diagnosis documentation (EEG confirmation preferred)
  • Age verification (≤2 years)
  • Monotherapy use (unless medically justified)

Refractory Complex Partial Seizures (Ages ≥2 years)

Step therapy usually required, documenting failure of:

  • At least 2-3 other antiseizure medications at adequate doses
  • Specific reasons for failure (lack of efficacy, intolerance, contraindications)
  • Duration of each trial (typically 2-3 months minimum)

Medical Exception Pathways

If step therapy applies but isn't appropriate:

  • Contraindications: Document specific medical reasons why required drugs cannot be used
  • Previous trials: Include records from other providers/states showing prior failures
  • Intolerance: Detail specific adverse effects that prevented adequate trials

Quantity Limits and Renewal Rules

Typical BCBS Quantity Limits

  • 500mg tablets: 180 tablets per 30 days (maximum 3g daily)
  • Powder packets: 60 packets per 30 days
  • Initial approvals: Usually 3-6 months
  • Renewals: Require documentation of continued benefit

Pediatric Dosing Considerations

For infantile spasms, weight-based dosing may exceed standard quantity limits:

  • Standard dose: 50mg/kg twice daily
  • Maximum: 150mg/kg/day
  • Include patient weight and dosing calculation in PA request

Renewal Requirements:

  • Seizure frequency/severity improvement documentation
  • Continued REMS compliance
  • Current ophthalmologic exam results (within 3 months)
  • Prescriber attestation of ongoing benefit

Required Diagnostics and Documentation

Essential Clinical Documentation

  1. Diagnosis confirmation:
    • ICD-10 codes (G40.4 for infantile spasms, G40.2 for complex partial)
    • EEG reports showing seizure patterns
    • Neurologist consultation notes
  2. Treatment history:
    • Complete list of prior antiseizure medications
    • Doses, durations, and specific outcomes
    • Reasons for discontinuation
  3. Vision monitoring:
    • Baseline ophthalmologic exam
    • Visual field testing results
    • Scheduled follow-up appointments every 3 months

REMS Documentation

Include in PA submission:

  • REMS enrollment confirmation numbers for prescriber, patient, and pharmacy
  • Signed patient agreement form
  • Vision monitoring schedule and baseline results

Specialty Pharmacy Requirements

BCBS New York plans typically require vigabatrin to be dispensed through:

  • In-network specialty pharmacies (preferred)
  • REMS-certified pharmacies (mandatory)
  • Mail-order specialty services (when available)

Key Considerations

  • Verify pharmacy is both BCBS-contracted AND REMS-certified
  • Coordinate between prescriber, pharmacy, and REMS program
  • Allow extra time for REMS verification with each fill
  • Maintain consistent pharmacy to avoid enrollment delays

Common BCBS-contracted specialty pharmacies include CVS Specialty, Walgreens Specialty, and Accredo, but confirm REMS certification before transferring prescriptions.

Evidence for Medical Necessity

Supporting Documentation

Include peer-reviewed evidence and guidelines in your appeal:

For Infantile Spasms:

  • American Academy of Neurology practice parameters
  • FDA labeling supporting first-line use
  • Evidence of vigabatrin's efficacy in tuberous sclerosis complex (if applicable)

For Refractory Seizures:

  • Epilepsy Foundation treatment guidelines
  • Cochrane reviews on vigabatrin efficacy
  • Documentation that formulary alternatives have failed

Medical Necessity Letter Template

Your neurologist's letter should include:

  1. Patient's seizure type, frequency, and severity
  2. Complete prior treatment history with outcomes
  3. Specific clinical rationale for vigabatrin
  4. Plan for monitoring and assessing benefit
  5. Citations to relevant guidelines or literature

Appeals Process in New York

Internal Appeals (Required First Step)

  • Deadline: 180 days from denial notice (verify with your specific plan)
  • Timeline: 15 days for pre-service appeals, 30 days for post-service
  • Expedited: 72 hours for urgent cases
  • Submit to: Your specific BCBS plan's appeals department

New York External Appeals

If internal appeal fails, use New York's external review process:

Eligibility: Denials for medical necessity, experimental/investigational status, or formulary restrictions

Timeline:

  • File within 4 months of final internal denial
  • Standard decision within 30 days
  • Expedited decision within 72 hours for urgent cases

How to File:

  1. Complete NY DFS External Appeal Application
  2. Include all denial letters and supporting documentation
  3. Submit neurologist's detailed medical necessity letter
  4. Attach relevant clinical guidelines and literature

Cost: $25 filing fee (waived for financial hardship or Medicaid)

From our advocates: "We've seen vigabatrin denials overturned when families included detailed seizure diaries showing frequency and severity, along with documentation of failed alternatives. The key is demonstrating that delay causes real harm, especially for infantile spasms where time is critical."

Common Denial Reasons & Solutions

Denial Reason Solution
Missing REMS enrollment Provide enrollment confirmation numbers for all parties
Insufficient prior trials Document specific medications, doses, durations, and failure reasons
Age restrictions Verify patient age and indication alignment with FDA labeling
Missing vision monitoring Include baseline ophthalmologic exam and monitoring schedule
Non-specialist prescriber Ensure neurologist prescription or consultation
Quantity exceeded Justify dosing with patient weight and clinical guidelines

Cost Assistance Options

Manufacturer Programs

  • Generic vigabatrin: Various manufacturer patient assistance programs
  • Sabril: Lundbeck's patient support programs (verify current offerings)

Foundation Support

  • Epilepsy Foundation assistance programs
  • State pharmaceutical assistance programs in New York
  • Hospital charity care programs

Insurance Optimization

  • Appeal to lower formulary tier if possible
  • Request 90-day supplies to reduce copays
  • Explore Medicare Part D if age-eligible

Checklist: What to Gather Before Starting

Before PA Submission:

  • Insurance card with specific BCBS plan identification
  • Current PA form from your BCBS entity's website
  • REMS enrollment completed for prescriber, patient, pharmacy
  • Complete seizure history and prior medication records
  • Baseline ophthalmologic exam scheduled or completed
  • Neurologist's medical necessity letter

For Appeals:

  • All denial letters and correspondence
  • Updated clinical documentation
  • Supporting literature and guidelines
  • Patient/family impact statement (for external appeals)

When to Escalate

Contact these New York resources for additional help:

  • New York Department of Financial Services: For external appeals and insurance complaints
  • Community Health Advocates: Free insurance counseling at 888-614-5400
  • Epilepsy Foundation New York: Patient advocacy and support services

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform ingests denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned to each plan's specific rules, pulling the right citations and weaving them into appeals with required clinical facts.

FAQ

Q: How long does BCBS prior authorization take in New York? A: Typically 15 days for pre-service requests, but can be expedited to 72 hours for urgent cases.

Q: What if vigabatrin is non-formulary on my plan? A: Request a formulary exception with medical necessity documentation and evidence that formulary alternatives have failed or are inappropriate.

Q: Can I request an expedited appeal? A: Yes, if delay would seriously jeopardize health. This applies especially to infantile spasms where treatment delay worsens prognosis.

Q: Does step therapy apply if I failed medications outside New York? A: Yes, but you must provide documentation of prior trials from other providers. BCBS should accept properly documented treatment history from any state.

Q: What happens if my external appeal is denied? A: The external review decision is binding on the insurer, but you can explore manufacturer assistance programs, consider alternative treatments, or reapply if clinical circumstances change.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific guidance. Coverage policies change frequently—verify current requirements with your specific BCBS plan.

For personalized help with complex denials and appeals, Counterforce Health provides specialized support in navigating insurance requirements and crafting evidence-based appeals that align with payer-specific workflows and procedural requirements.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.